SEC Company Response from Antiaging Quantum Living Inc. (AAQL) (CIK 0001672571) (AAQL) — Mar 24, 2017
Antiaging Quantum Living Inc. (AAQL) (CIK 0001672571)
Date: March 24, 2017 · CIK: 0001672571 · Accession: 0001672571-17-000004
AI Filing Summary & Sentiment
File numbers found in text: 333-211051
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
CORRESP for the SEC letter of the Registration Satement on Form S-1
Achison INC
CIK: 0001672571
3906 Main Street, 207
Flushing, NY11354
March 24, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Real Estate and Commodities
100 F Street, N.E.
Washington, DC 20549
Attention:
Folake Ayoola
Stacie Gorman
Paul Cline
Wilson Lee
Re: Achison Inc
Amendment No. 7 to Registration Satement on Form S-1
Filed February 15, 2017
File No. 333-211051
The follow contents are in response to the SEC letter on March 13, 2017 for the Registration Satement on Form S-1:
General
1. We note your response to our prior comments 1, 2 and 11, and your disclosure in the
prospectus summary and in the liquidity section that Lansdale is a holding company. Please
supplementally tell us the entities owned by Lansdale. Also clarify whether Lansdale is your
parent company and if it holds or intends to hold sufficient shares to become your parent
company. In this regard, we note your disclosure in the liquidity section that Lansdale Inc.
will resell some of your shares after two years.
Please see the amended contents of the Prospectus Summary 4 on page 6 of Form S-1/A on March 24, 2017.
Prospectus Cover Page
2. We note your disclosure that the offering will end 29 days after the registration statement is
effective. Please tell us the basis for this time frame, including how you intend to sell 99.9
billion shares within 29 days. In this regard, we remind you of the undertaking in Item
512(a)(3), which requires you to remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of
the offering. Alternatively, refer to Rule 415(a)(2) for guidance in setting the appropriate
time frame.
Please see the amended contents of the Prospectus Cover Page 8 on page 3 of Form S-1/A on March 24, 2017.
Prospectus Summary, page 6
3. We note your response to our prior comments 11 and 15. Please revise paragraph 3 to state
that you will reimburse Blueville, Inc. and clarify the amount owed to date. Also, revise your
disclosure in the "Other Expenses of Issuance and Distribution" section to indicate, if true,
that the $13,800 will be reimbursed.
Please see the amended contents of the Prospectus Summary 3 on page 6 of Form S-1/A on March 24, 2017.
Exhibit 5, Legal Opinion
4. We refer to paragraph 6 of the opinion where counsel assumes that the issuance and delivery
of the Registered Securities will not violate any applicable law, rule or regulation to which
the company is subject. It is inappropriate for counsel to include in its opinion assumptions
that assume any of the material facts underlying the opinion or any readily ascertainable
facts. Please ask counsel to revise the opinion to delete this assumption. Refer to the Division
of Corporation Finance's Staff Legal Bulletin No. 19 for guidance.
Please see the amended contents of the Exhibit 5, Legal Opinion of Form S-1/A on March 24, 2017.
5. We note your response to our prior comment 18. Assumption (vii) in paragraph 7 continues
to assume that you have a sufficient number of authorized shares as of the date of the
opinion. Please have counsel revise the legal opinion to delete the assumption and to clarify
separately that, as of the date of the opinion, you have a sufficient number of authorized
shares. Refer to the Division of Corporation Finance's Staff Legal Bulletin No. 19 for
guidance.
Please see the amended contents of the Exhibit 5, Legal Opinion of Form S-1/A on March 24, 2017.
Wanjun Xie
Wanjun Xie
President
Achison Inc
Date: March 24, 2017